Fitlens Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

Fitlens General Information

Description

Manufacturer of vision management products designed to address refractive errors and eye diseases. The company mainly focuses on the design and production of high-end complex optical design contact lenses and the design and production of high-end intraocular lens optical molds, enabling clients to have high-quality optical products.

Contact Information

Website
fitlens.co.il
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Area A, 3rd Floor, R&D Workshop, No. 1 Huaguan Road
  • Tangjiawan Town, High-tech Zone
  • Zhuhai, Guangdong 519085
  • China
+86 137
Primary Industry
Therapeutic Devices
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • Area A, 3rd Floor, R&D Workshop, No. 1 Huaguan Road
  • Tangjiawan Town, High-tech Zone
  • Zhuhai, Guangdong 519085
  • China
+86 137

Fitlens Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fitlens Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 22-Mar-2023 Completed Generating Revenue
6. Early Stage VC (Series B) 12-Dec-2022 Completed Generating Revenue
5. Early Stage VC 29-Dec-2021 Completed Generating Revenue
4. Early Stage VC 01-Nov-2021 Completed Generating Revenue
3. Early Stage VC (Series A1) 01-Sep-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 22-Apr-2021 $12.8M $12.8M Completed Generating Revenue
1. Seed Round 08-Feb-2021 Completed Startup
To view Fitlens’s complete valuation and funding history, request access »

Fitlens Patents

  • 23

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

Fitlens Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026184042-A1 Ophthalmic lens, manufacturing method for ophthalmic lens, and spectacles Pending 06-Mar-2025
WO-2026152718-A1 Orthokeratology lens Pending 15-Jan-2025
WO-2026138232-A1 Optimization design method for rigid gas permeable contact lens and rigid gas permeable contact lens Pending 25-Dec-2024
WO-2026046213-A1 Direct-current electrical signal output control apparatus Pending 27-Aug-2024
EP-4336248-A1 Ophthalmic lens and frame glasses having same Pending 30-May-2022 G02C7/022
To view Fitlens’s complete patent history, request access »

Fitlens Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioTrack Capital Venture Capital Minority
China Growth Capital Venture Capital Minority
Qiming Venture Partners Venture Capital Minority
Zhuhai Huajin Capital Corporation Minority
Rimonci Capital Venture Capital Minority
To view Fitlens’s complete investors history, request access »

Ready to get started?

Request a free trial

Fitlens FAQs

  • When was Fitlens founded?

    Fitlens was founded in 2021.

  • Where is Fitlens headquartered?

    Fitlens is headquartered in Zhuhai, China.

  • What industry is Fitlens in?

    Fitlens’s primary industry is Therapeutic Devices.

  • Is Fitlens a private or public company?

    Fitlens is a Private company.

  • What is Fitlens’s current revenue?

    The current revenue for Fitlens is .

  • How much funding has Fitlens raised over time?

    Fitlens has raised $96.3M.

  • Who are Fitlens’s investors?

    BioTrack Capital, China Growth Capital, Qiming Venture Partners, Zhuhai Huajin Capital, and Rimonci Capital have invested in Fitlens.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process